baber/WOPTO huggingface dataset:
Patent DE-69414797-T2 (DE)
Inventor: SUIKKOLA RAUNO
IPC: H04W4/02
Filed: 1994-03-01
Granted: 1999-05-06
Abstract: PCT No. PCT/FI94/00074 Sec. 371 Date Oct. 27, 1994 Sec. 102(e) Date Oct. 27, 1994 PCT Filed Mar. 1, 1994 PCT Pub. No. WO94/21075 PCT Pub. Date Sep. 15, 1994A method for use in a radio system that includes a subscriber database containing data informing of facilities activated for the subscriber, exchanges, base stations and subscriber stations. In order to keep the subscriber stations informed of the facilities activated therefor, the facility data for a given subscriber station are read from the subscriber data base of the radio system and the data are sent as a facility data message through a base station via a radio path to the subscriber station, the subscriber station receives the message containing the facility data and presents these data to the subscriber.
Patent DE-69434721-T2 (DE)
Inventor: ZIMMERMANN JUERG
IPC: C07D239/42
Filed: 1994-09-21
Granted: 2006-11-09
Abstract: PCT No. PCT/EP94/03148 Sec. 371 Date May 31, 1995 Sec. 102(e) Date May 31, 1995 PCT Filed Sep. 21, 1994 PCT Pub. No. WO95/09851 PCT Pub. Date Apr. 13, 1995Described are N-phenyl-2-pyrimidineamine derivatives of formula I    <IMAGE>  (I)  wherein R1 is a substituted cyclic radical, the cyclic radical being bonded at a ring carbon atom in each case and being selected from phenyl, pyridyl, pyrazinyl, thiazolyl, pyrimidinyl, pyridazinyl and imidazolyl, and the substituents of the above-mentioned cyclic radical being selected from one or more of the groups halogen, cyano, carbamoyl, -C(=O)-OR3, -C(=O)-R4, -SO2-N(R5)-R6, -N(R7)-R8, -OR9 and fluorine-substituted lower alkyl, wherein R3, R4, R5, R6, R7, R8 and R9 are each independently of the others hydrogen or lower alkyl that is unsubstituted or substituted by mono- or di-lower alkylamino; and R2 is selected from halogen, cyano, carbamoyl, -C(=O)-OR10, -C(=O)-R11, -SO2-N(R12)-R13, -N(R14)-R15, -OR16 and fluorine-substituted lower alkyl, wherein R10, R11, R12, R13, R14, R15 and R16 are each independently of the others hydrogen or lower alkyl that is unsubstituted or substituted by mono- or di-lower alkylamino. Those compounds can be used, for example, in the treatment of tumour diseases.
Patent DE-69434769-T2 (DE)
Inventor: MULQUEEN PATRICK J
IPC: C09K23/00
Filed: 1994-09-14
Granted: 2006-10-12
Abstract: PCT No. PCT/US94/10416 Sec. 371 Date Aug. 2, 1996 Sec. 102(e) Date Aug. 2, 1996 PCT Filed Sep. 14, 1994 PCT Pub. No. WO95/07614 PCT Pub. Date Mar. 23, 1995A formulation e.g., a pesticidal formulation in the form of a dispersion comprising a continuous aqueous phase, and a discontinuous phase comprising a non-aaueous material capable of transport through the aqueous phase to cause Ostwald ripening of the dispersion, wherein there is contained within the discontinuous phase a pesticidal material, which may or may not be the said non-aqueous material, wherein the discontinuous phase comprises a stabiliser in an amount sufficient to depress migration of the non-aqueous material through the aqueous phase, and thereby diminish or prevent Ostwald ripening of the dispersion, characterised in that the stabiliser has a molecular weight of not more than 10,000, and is soluble in the discontinuous phase, but insoluble in and not transportable through the aqueous phase. The production of the formulation can be carried out in a metered in-line mixing plant, since the thermodynamics of the mixing process is such that the particle size tends to a predictable value.
Patent DE-69504640-T2 (DE)
Inventor: WOOD JOHN
IPC: A61K6/04
Filed: 1995-03-06
Granted: 1999-05-20
Abstract: PCT No. PCT/GB95/00486 Sec. 371 Date Nov. 19, 1996 Sec. 102(e) Date Nov. 19, 1996 PCT Filed Mar. 6, 1995 PCT Pub. No. WO95/23876 PCT Pub. Date Sep. 8, 1995A method of treatment of a shape memory alloy involves shot peening of the alloy sample, thereby causing a crystal to amorphous transition of a surface layer of the sample without substantially affecting bulk characteristics of the material, particularly its shape memory behavior and biocompatibility. The method may be used for surface hardening and to reduce coefficients of friction. The method may be advantageously used for treating tissue sutures and orthodontic devices such as dental archwires.
Patent DE-69504861-T2 (DE)
Inventor: FUSCO ELIO
IPC: B42D15/00
Filed: 1995-11-14
Granted: 1999-03-04
Abstract: The transparent safety film is made up of a thin self-adhesive structure, comprising reflecting metal holograms in limited areas, perfectly visible and suitably distributed, allowing the contents on the surface of the document or object to be protected to be seen. The manufacturing process is also described.
Patent DE-69508021-T2 (DE)
Inventor: KUJAWSKI RICK A
IPC: F16L21/00
Filed: 1995-09-18
Granted: 1999-08-05
Abstract: A quick connector coupling for a fluid line includes a hollow female connector body (20) defining an interior radial bearing surface (56). A male member (200) has a radially enlarged upset (202) and is insertable into the connector body to a first position and withdrawable from the first position to a second position within the connector body. A retainer (100) is disposed in the connector body and has retention beams (120) extending between the upset and the bearing surface (56) to secure the retainer and the male member in the connector body. A ring-shaped indicator member (130) is detachably secured to one end of the connector body. Withdrawal of the male member from the first position to the second position causes detachment of the indicator member from the connector body and signals a proper coupling. <IMAGE>
Patent DE-69509415-T2 (DE)
Inventor: CASTELIJNS ANNA
IPC: C07C45/62
Filed: 1995-10-17
Granted: 1999-12-16
Abstract: Process for the preparation of 3-phenylpropionic acid in which 3-phenylpropanal is subjected to an oxidation, at elevated temperature, in particular at a temperature of between 40 DEG  and 80 DEG  C., using a medium containing molecular oxygen. A high degree of conversion and a high selectivity are obtained. The starting material 3-phenylpropanal can be prepared in a suitable manner through the hydrogenation of cinnamaldehyde in the presence of a Pd-containing catalyst, after which the reaction mixture obtained can without intermediate further processing be used in the oxidation reaction. The combination of the two process steps constitutes a simple, commercially attractive process for the preparation of 3-phenylpropionic acid using cinnamaldehyde as a starting material. 3-phenylpropionic acid can be used in particular in the preparation of pharmaceuticals such as HIV protease inhibitors.
Patent DE-69604389-T2 (DE)
Inventor: MARR KENNETH
IPC: G11C7/00
Filed: 1996-03-12
Granted: 2000-02-17
Abstract: A circuit and method provide isolated modulation of SRAM bitline voltage levels for improved voltage bump retention testing of the SRAM cells. A first FET is connected to Vcc, bitline load gates of the SRAM cell, and test mode operation control logic. A second FET is connected to the bitline load gates, the test mode logic, and an external pin of the SRAM device. During test mode operation, the first FET disables Vcc to the bitlines, and the second FET enables the internal bitline voltage levels to be modulated by a voltage supply received through the external pin of the device. Modulation of the bitline voltage levels is isolated from normal operating voltage levels of peripheral circuitry such as the wordlines. An alternate embodiment provides a CMOS transmission gate in place of the second FET.
Patent DE-69622124-T2 (DE)
Inventor: ROCHAT JEAN-DENIS
IPC: A61J1/10
Filed: 1996-10-17
Granted: 2003-02-06
Abstract: The pouch has two internal chambers separated by a filtering grille (11) and connected to the exterior via inlet (4) and outlet (6) openings passing through the wall of the pouch. The wall is defined by a pair of plastics sheets (1,2), with the inlet and outlet openings, and a further air suction outlet opening (5), all formed in the same sheet. The internal grille is attached to the inner surface of the wall sheet which includes the openings. The surface area of the grille is less than the area of the wall sheet to which it is attached, and it is welded to the wall sheet at its periphery (14) and at a number of internal points (16) such that it defines at least one compartment within the pouch.
Patent DE-69625278-T2 (DE)
Inventor: YAMAMOTO TAKASHI
IPC: G09G3/20
Filed: 1996-05-31
Granted: 2003-09-04
Abstract: In a display apparatus for receiving and displaying display image data, whether or not a cable is disconnected from an interface connector for receiving display data is detected. If the disconnection state is detected, a predetermined indication portion is driven to inform this state. <IMAGE>
Patent DE-69630696-T2 (DE)
Inventor: CLARKE JOSEPH
IPC: F25C1/22
Filed: 1996-07-08
Granted: 2004-09-16
Abstract: A method and apparatus for moulding ice statues using a mould formed of a liquid impervious flexible material which defines a mould cavity having the shape of the statue to be formed and a pair of extending wall portions which are held in a juxtaposed attitude during the freezing process. For demoulding, the wall portions are moved apart to increase the cross-sectional size of the mould to allow it to be released from the statue formed.
Patent DE-69636658-T2 (DE)
Inventor: BAUER C
IPC: C12N15/09
Filed: 1996-12-05
Granted: 2007-02-01
Abstract: The invention provides improved method of introducing site-directed mutations into circular DNA molecules of interest by means of mutagenic primer pairs. The mutagenic primer pairs are also selected so as to be either completely complementary or partially complementary to each other, wherein the mutation site (or sites) is located within the region of complementarity. A mutagenic primer pair is annealed to opposite strands of a circular DNA molecule containing the DNA sequence to be mutagenized. After annealing, first and second mutagenized DNA strands , each incorporating a member of the mutagenic oligonucleotide primer pair is synthesized by a linear cyclic amplification reaction. After the linear cyclic amplification mediated synthesis step is completed, the reaction mixture is treated with a section enzyme that digests the parental template strands. After the digesting step, a double-stranded circular DNA intermediate is formed. The double-stranded circular DNA intermediates are transformed in suitable competent host cells and closed circular double-stranded DNA corresponding to the parental template molecules, but containing the desired mutation or mutations of interest, may be conveniently recovered from the transformed cells. The invention also provides kits for site-directed mutagenesis in accordance with methods of the present invention.
Patent DE-69637123-T2 (DE)
Inventor: GORDON ERLINDA M
IPC: A61K45/00
Filed: 1996-10-31
Granted: 2008-02-14
Abstract: A method of treating a tumor (in particular osteosarcoma or Ewing's sarcoma) in a host by administering to a host or to the tumor cells an agent which inhibits cyclin G1 protein in an amount effective to inhibit cyclin G1 protein in tumor cells of the host. The agent may be an antisense polynucleotide which is complementary to at least a portion of a polynucleotide encoding cyclin G1 protein, or an antibody or fragment or derivative thereof which recognizes cyclin G1 protein. Also contemplated within the scope of the present invention are (i) the immortalization of cell lines by transducing cells with a polynucleotide encoding cyclin G1 protein; (ii) increasing the receptiveness of cells to retroviral infection by transducing cells with a polynucleotide encoding cyclin G1 protein; and (iii) the detection of cancer by detecting cyclin G1 protein or a polynucleotide encoding cyclin G1 protein in cells. In addition, the present invention provides expression vehicles, such as, for example, retroviral vectors and adenoviral vectors, which include polynucleotides which encode agents which inhibit cyclin G1 protein, and expression vehicles which include a polynucleotide encoding cyclin G1 protein.
Patent DE-69705257-T2 (DE)
Inventor: MORIN JEAN-CLAUDE
IPC: C21D1/76
Filed: 1997-04-08
Granted: 2002-04-18
Abstract: Making a heat treatment atmosphere by catalytic reaction between a first gaseous mixture (2/3) containing oxygen and a second gaseous mixture (4) containing a hydrocarbon in a catalytic reactor (16) with the intention of feeding this atmosphere to a user site containing at least one user position (F1, F2, F3) is such that: (a) the pressure of the atmosphere is measured continuously at the outlet from the reactor; (b) the measured pressure is compared to a sending pressure Pc; and (c) as a result of this comparison, the flows of the first and second gaseous mixtures are varied to raise the measured pressure to the required pressure Pc. Also claimed are a process of controlling the manufacture of a heat treatment atmosphere and an apparatus for carrying out the above process.
Patent DE-69712664-T2 (DE)
Inventor: NOTTER DAVID A
IPC: F16J15/32
Filed: 1997-03-07
Granted: 2002-10-24
Abstract: A fluid seal including a casing unit (12) and an elastomeric lip body portion (30). Frustoconical air and oil side surfaces (34;32) of the lip body (30) meet at an inner diameter portion to form a fluid seal band (36) contacting an associated shaft in use. A continuous, circumferentially extending garter spring (38) is embedded in the seal lip body (30). An axially inner surface of the lip body (30) is defined in part by plural spaced apart ribs (48) and the remainder is defined by pockets (46) having portions lying closely adjacent the radially and axially innermost portions of the garter spring (38). In the free state of said seal, the garter spring (38) exerts a radially inwardly directed preload force so as to resist radially expansion of said seal. The spring also resists dimensional shrinkage of the seal band and the remainder of the seal body. <IMAGE>   <IMAGE>
Patent DE-69714302-T2 (DE)
Inventor: BEN-SHALOM ZVI
IPC: G05D7/06
Filed: 1997-09-01
Granted: 2003-04-03
Abstract: PCT No. PCT/IL97/00289 Sec. 371 Date Aug. 18, 1998 Sec. 102(e) Date Aug. 18, 1998 PCT Filed Sep. 1, 1997 PCT Pub. No. WO98/53233 PCT Pub. Date Nov. 26, 1998An electromagnetic flow control apparatus includes a fluid flow conduit, a magnetic membrane, and a plurality of discrete sources of selectably variable magnetic fields, such as electromagnets, arranged in an ordered array, to drive the membrane in a desired manner to control the flow of fluid in the conduit. The membrane can preferably be driven between two extreme positions wherein the flow of fluid in the conduit is totally unrestricted in the rest position of the membrane and wherein the flow is highly restricted or stopped completely in the maximum deformation of the membrane radially inward.
Patent DE-69714754-T2 (DE)
Inventor: SAIRANEN MARTTI
IPC: H02M7/537
Filed: 1997-10-17
Granted: 2003-04-30
Abstract: The present invention relates to an electronic power control with a switched-mode power supply, especially for a dimmer application. The power control comprises a half bridge control unit (2) having an oscillator circuit (5) and two control units (6, 7) and at least two switching elements, such as field effect transistors (8, 9) being preferably arranged in a half bridge configuration and which are connected by their gates to the outputs of the control units (6, 7) of the half bridge control unit (2). The switching time of the switching elements (8, 9), and thereby also the electrical power fed to the load (K), can be changed by changing the duty cycle of the oscillator circuit (5) output voltage. The half bridge control unit (2) is provided with terminals (5a, 5b) for connecting external components, especially a resistor and a capacitor thereto for setting the operating frequency of the half bridge control unit. According to the invention, the operating frequency terminals (5a, 5b) of the half bridge control unit (2) are provided with an active resistor circuit (14) and a capacitor (14), known as such. The active resistor circuit (14) comprises two adjustable resistors (16, 17), the first (16) of which is arranged to operate when the capacitor (15) is being charged and the second (17) of which is arranged to operate when the capacitor (15) is being discharged.
Patent DE-69721497-T2 (DE)
Inventor: FURDA IVAN
IPC: A61K31/715
Filed: 1997-02-04
Granted: 2004-03-18
Abstract: Chitosan is formulated with nicotinic acid and may additionally contain one or more other vitamin acids, such as ascorbic acid, folic acid, pantothenic acid, or biotin, for oral administration to enhance cholesterol reduction and high-density lipoprotein elevation in blood serum. In addition, such formulations reduce the pH of large intestine which is beneficial in colon etiology. The formulation may be in dosage unit form for daily administration of, for example, 2-18 g of chitosan and 50-3,000 mg of nicotinic acid.
Patent DE-69721889-T2 (DE)
Inventor: DAVIES CHRISTOPHER JOHN
IPC: G01N33/53
Filed: 1997-03-24
Granted: 2004-06-17
Abstract: There is disclosed a method for antenatal screening for an abnormality in a fetus using a bodily fluid, the fluid containing a marker which at one stage of gestation (stage A) the mean or median level of the marker differs by less than 20% between pregnancies which are affected and unaffected by the abnormality and at another stage of gestation (stage B) differs by more than 50% between such affected and unaffected pregnancies, there being a period of at least 3 weeks between Stage A and Stage B, characterised in that determinations of concentrations of the marker for an individual woman are made at stage A and at stage B and are compared to produce a normalised concentration and the thus determined normalised concentration is compared with similarly determined normalised concentrations for populations of women with and without said fetal abnormality and an apparatus for carrying out the method.
Patent DE-69724415-T2 (DE)
Inventor: YANIK GARY W
IPC: G01N21/21
Filed: 1997-01-27
Granted: 2004-03-18
Abstract: An improved optical rotation detector for detecting optically active molecular compounds in a sample solution using: a laser diode with the beam passing through an optical fiber or lens to improve its quality, a reference oscillator at frequency f, a first polarizer, a specially constructed flow cell to minimize mechanical birefringence and leaking in the cell's optical windows, a second polarizer, and an improved detection scheme. The detection scheme includes a first and second photodetector for sensing first and second signals, where the first signal is light passed through the second polarizer and the second signal is light reflected off the second polarizer. A compensator circuit low pass filters the signals, inverts one signal and sums it with the other, and then notch filters off the undesired components to produce a compensated signal. The compensated signal then drives a lock-in amplifier which is driven by the reference oscillator to sense the amplitude modulated f frequency signal. This compensated signal indicates the optical activity of the sample, yet is immune to laser power fluctuations.
Patent DE-69725436-T2 (DE)
Inventor: WOOD M
IPC: E21B43/12
Filed: 1997-04-24
Granted: 2004-07-29
Abstract: The stator, rotor and/or flex shaft of a progressive cavity pump is made up of composite materials, e.g., fiberglass and resin, in a variety of combinations with and without bonded resilient elastomers. The composites are formulated to provide resiliency and non-resiliency where needed. The flex shaft between the rotary power source and the rotor is made of composite materials and designed to absorb the orbital and gyrational movement of the rotor.
Patent DE-69727522-T2 (DE)
Inventor: JENKINS MICHAEL D
IPC: G06F1/18
Filed: 1997-04-04
Granted: 2004-08-05
Abstract: A body-worn computer (1) that is easily converted into a conventional or laptop computer. This body-worn computer has a compartment (26) for enclosing the entire PC card (28) being used, and a second compartment for housing a removable hard drive. Also in the housing (2) of this computer are located an opening for an IrDA transceiver and offset connections for protecting connectors to peripherals. <IMAGE>
Patent DE-69729012-T2 (DE)
Inventor: MANKER C
IPC: A01N63/10
Filed: 1997-03-13
Granted: 2005-04-28
Abstract: This invention provides a method for repelling biting insects such as mosquitoes by topically applying to the skin of a subject fractions of emu oil obtained by flash chromatography. Also provided are methods for repelling biting insects by topically applying diluted fractions of emu oil. The invention also provides a compound useful in repelling biting insects having the NMR spectrum of FIG. 3, that is ultra violet light sensitive and is reactive to vanillin/sulfuric acid. Also provided are compounds useful in repelling biting insects having the NMR spectrum of FIG. 4, that is not ultra violet light sensitive and is not reactive to vanillin/sulfuric acid.
Patent DE-69808426-T2 (DE)
Inventor: MURRAY A
IPC: E04C2/52
Filed: 1998-01-15
Granted: 2003-07-10
Abstract: Communications cable is routed within horizontal pathways between the structural ceiling and drop ceiling to a fire-resistant cabinet mounted between the ceilings. Communication cable switching and termination equipment is carried by the cabinet for providing a consolidation point and cross-connect location for both copper wire and optical fiber cables serving work stations within an open office architecture. The cabinet includes an access door opening into a room below the drop ceiling for providing user access to the equipment. The door lies within the drop ceiling plane when in the closed position. A removable equipment mounting plate is carried by the cabinet for lowering the equipment below the drop ceiling when the door is in the open position. Cabinet fire-resistant side wall penetrations permits the communications cable routed between the ceilings to enter and exit the cabinet for connection with the communications cable switching and termination equipment. With the use of the cabinet, the amount of communication cable required to service work stations in an open office architecture is greatly reduced.
Patent DE-69811962-T2 (DE)
Inventor: MULLER W
IPC: A61P29/00
Filed: 1998-11-17
Granted: 2003-08-28
Abstract: 1-Oxo-2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and 1,3-dioxo-2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines reduce the levels of inflammatory cytokines such as TNF alpha in a mammal. A typical embodiment is 1,3-dioxo-2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindoline.
Patent DE-69814673-T2 (DE)
Inventor: SIMON BELA
IPC: A47C9/00
Filed: 1998-10-12
Granted: 2004-03-25
Abstract: Seating furniture including a substructure (4) having a pedestal arrangement (43, 44) which is arranged to rest securely on an underlying surface (5), a chair seat (2) which is supported by the substructure (4), and means (6; 422, 423, 424) for setting a desired distance between the pedestal arrangement (43, 44) and the seat (2). A driving means (7; 71-73, 75, 425, 9, 77, 78) is provided for the substantially continuous driving of the means (6; 422, 423, 424) for the purpose of slowly changing the distance (S) with a velocity of motion not exceeding 100 cm/minute.
Patent DE-69825322-T2 (DE)
Inventor: COLES MARC
IPC: A61Q19/00
Filed: 1998-12-18
Granted: 2005-07-14
Abstract: A therapeutic formulation comprises a topically acceptable semisolid vehicle and carbamazepine, the vehicle consisting of components that are compatible with the carbamazepine, and the carbamazepine being in a concentration sufficient to permit a therapeutically effective amount of the carbamazepine to be absorbed from the formulation into the skin of a patient. The vehicle may be a cream, ointment, or gel. A method of treating a skin condition of a patient such as psoriasis comprises applying carbamazepine topically to the patient's skin until the condition improves. A method of administering carbamazepine to a patient comprises applying a formulation comprising carbamazepine topically to the patient's skin.